There have been burgeoning developments in nanoparticle (NP) research for biomedical applications and nanomedicine. However, very few NPs have made it to clinical trials, and even fewer have reached clinical practice. This wide disparity between bench discoveries and their effective clinical translation is mainly due to insufficient knowledge of the nano-bio interface. We believe that there are multiple factors in the in vitro environment that are overlooked leading to misinterpretation of data that is collected. Recently, several studies have been performed to diminish the aforementioned gap aimed at achieving a more in-depth understanding of the biological identity of NPs and their inherent cytotoxic properties. However, there is still a ...
Therapeutic nanoparticles (NPs) are used in nanomedicine as drug carriers or imaging agents, providi...
Whether one wishes to optimise drug delivery using nano-sized carriers or avoid hazard posed by engi...
Nanotechnology is a new, interdisciplinary field of science, the products of which are nanoparticles...
Nanoparticles (NPs) are used extensively in drug delivery. They are administered through various rou...
Nanoparticles have great potential for drug delivery (nanomedicine), because of their size (few to h...
Cancer persists as a major public health concern with poor survival rates for aggressive tumours. Na...
Nanoparticles are small objects in the scale of nanometres (a billionth of a metre), used for a wide...
The use of nanoparticles (NP) in diagnosis and treatment of many human diseases, including cancer, i...
The revolutionary development of nanoscience during the last years has increased the number of studi...
The growing wealth of information regarding the influence that physicochemical characteristics play ...
Over the past decade, there has been an exponential growth in products and applications that utilize...
Understanding and controlling the biological response to nanoparticles is essential to designing saf...
Nanoparticles (NPs) have gained a lot of interest in recent years due to their huge potential for ap...
Des différences de propriétés mé- caniques entre les cellules saines et les cel- lules cancéreuses o...
Therapeutic nanoparticles (NPs) are used in nanomedicine as drug carriers or imaging agents, providi...
Whether one wishes to optimise drug delivery using nano-sized carriers or avoid hazard posed by engi...
Nanotechnology is a new, interdisciplinary field of science, the products of which are nanoparticles...
Nanoparticles (NPs) are used extensively in drug delivery. They are administered through various rou...
Nanoparticles have great potential for drug delivery (nanomedicine), because of their size (few to h...
Cancer persists as a major public health concern with poor survival rates for aggressive tumours. Na...
Nanoparticles are small objects in the scale of nanometres (a billionth of a metre), used for a wide...
The use of nanoparticles (NP) in diagnosis and treatment of many human diseases, including cancer, i...
The revolutionary development of nanoscience during the last years has increased the number of studi...
The growing wealth of information regarding the influence that physicochemical characteristics play ...
Over the past decade, there has been an exponential growth in products and applications that utilize...
Understanding and controlling the biological response to nanoparticles is essential to designing saf...
Nanoparticles (NPs) have gained a lot of interest in recent years due to their huge potential for ap...
Des différences de propriétés mé- caniques entre les cellules saines et les cel- lules cancéreuses o...
Therapeutic nanoparticles (NPs) are used in nanomedicine as drug carriers or imaging agents, providi...
Whether one wishes to optimise drug delivery using nano-sized carriers or avoid hazard posed by engi...
Nanotechnology is a new, interdisciplinary field of science, the products of which are nanoparticles...